Grifols (Grifols) Price-to-Operating-Cash-Flow

: (As of Today)

View and export this data going back to 2011. Start your Free Trial

As of today (2024-04-18), Grifols's share price is $6.54. Grifols's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00. Hence, Grifols's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Grifols's Price-to-Operating-Cash-Flow or its related term are showing as below:

GRFS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 11.35 Med: 20.38 Max: 41.7
Current: 28.93

During the past 13 years, Grifols's highest Price-to-Operating-Cash-Flow Ratio was 41.70. The lowest was 11.35. And the median was 20.38.

GRFS's Price-to-Operating-Cash-Flow is ranked worse than
70.52% of 675 companies
in the Drug Manufacturers industry
Industry Median: 17.28 vs GRFS: 28.93

Grifols's Cash Flow from Operations per share for the three months ended in Sep. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -42.60% per year.

During the past 13 years, Grifols's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.90% per year. The lowest was -42.60% per year. And the median was 9.60% per year.

Grifols Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Grifols's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

37.87

14.74

19.26

34.61

Grifols Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																-	-	-	-	-

Competitive Comparison

For the Drug Manufacturers - General subindustry, Grifols's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Grifols's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Grifols's Price-to-Operating-Cash-Flow falls into.

Grifols Price-to-Operating-Cash-Flow Calculation

Grifols's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	6.54	/	0
	=

Grifols's Share Price of today is $6.54.
Grifols's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Grifols Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Grifols's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols (Grifols) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

GIKLY:USA GIFOF:USA GIFLF:USA GRFP:Mexico GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0F0:Germany G0F:Germany G0FB:Germany OZTA:Germany OZTA:Germany G0FB:Germany

Address

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.